NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lexogen

Lexogen

Private
ViennaHealthcare & Life Scienceshttps://www.lexogen.com/

Last Round

Grant

Apr 29, 2020

Total Funding Raised

$13,000

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Lexogen is a biotechnology company that develops and sells technologies and kits for RNA analysis and offers end-to-end Next-Generation Sequencing (NGS) services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Infrastructure

Keywords

transcriptomicsNGSRNA-Seqlibrary prep kitsgene expression analysisnext-generation sequencing3' mRNA-SeqNGS serviceslow-input RNA sequencingFFPE RNA sequencingsequencing reagentsrRNA depletionfunctional genomicsdrug discoverybiomarker discoverybioinformatics servicesspike-in RNA variant controlsSIRVsbioinformatics software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lexogen Comparables

Compare Lexogen with similar companies based on industry and business-model similarity.

Lexogen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alithea Genomics
83%
SeqWell
77%
Danaher Corporation
77%

Lexogen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 29, 2020
GrantJan 1, 2012
AcceleratorAug 1, 2007

Key People

Founding team and executive leadership

Stephane Barges

Chief Executive Officer

Executive Team

Lena Nagy

CFO

Executive Team

Lexogen Investors

Notable investors and investment history

Lexogen investors
InvestorRounds
Austria WirtschaftsserviceSeed
FFG Austrian Research Promotion AgencyGrant
INiTSAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 102, 170% of current headcount.

  • Jan 26, 2026

    Monthly visitors increased 31% MoM to 21.6K.

Lexogen Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lexogen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lexogen's valuation, stock price, and market status.

Firmographic Details

HeadquartersVienna
Employee Range60
Year Founded2007
Last FundingApr 29, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.